Miosta H®
New generation drugIt is a new receptor drug for the treatment of nutritional dystrophy and protein-energy deficiency (PEM) in cattle, sheep and goats.
Miosta S®
New generation drugA new prescription drug for normalization of protein-energy deficiency and stimulation of muscle mass growth in pigs.
Our Products
Miosta H®
A new receptor-based product for treating alimentary dystrophy and protein-energy deficiency (PED) in cattle.
Miosta S®
A new prescription drug for normalization of protein-energy deficiency (BEN) and stimulation of muscle mass growth in pigs.
Honesty and straightforwardness
Each employee maintains the highest ethical standards and acts to protect and comply with the policies and procedures necessary to produce quality pharmaceutical products.
Quality and safety
The company is committed to producing safe and effective products and providing reliable information and services to our partners. We also have strict guidelines for all our stakeholders to ensure that CSR is maintained in accordance with the corporate culture.
Innovation and continuous improvement
Each employee promotes and supports continuous efforts that lead to improvements in our processes, products, services and workplace.
